Review by Thromboembolic Risk Factors Consensus Group was misquotedBMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7000.331a (Published 29 July 1995) Cite this as: BMJ 1995;311:331
- Gordon D O Lowe
- Professor of medicine Glasgow Royal Infirmary, Glasgow G31 2ER
EDITOR,--Christopher J K Bulstrode suggests that “the risk of death from pulmonary embolus after total hip replacement has been overestimated and anticoagulants should not be used routinely.”1 He misquotes the review by the Thromboembolic Risk Factors Consensus Group, which did not “try to persuade surgeons that all patients undergoing major surgery should receive prophylactic anticoagulation”; it recommended that patients at moderate or high risk of venous thromboembolism should receive specific antithrombotic prophylaxis of proved efficacy (either antithrombotic drugs or mechanical prophylaxis).2 Neither did the review argue that “the complications of anticoagulation are both rare and of no significance”; it specifically noted …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial